Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.20
Ask: 1.30
Change: 0.025 (2.04%)
Spread: 0.10 (8.333%)
Open: 1.225
High: 1.275
Low: 1.225
Prev. Close: 1.225
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Innovations Disappointed At Having To Sell Polarean Shares

Fri, 11th Oct 2019 10:49

(Alliance News) - Amphion Innovations PLC on Friday said it has sold its entire holding in Polarean Imaging PLC, and estimates proceeds of USD2.5 million.

On Thursday last week, Amphion sold 750,000 shares in partner company Polarean for the partial repayment of a loan facility.

The developer of medical, life science, and technology businesses on Friday said it has disposed of a further 16.0 million shares, or a 14% holding.

The company noted its interest in Polarean was pledged as security against a loan facility and the shares were sold as part of this security arrangement. Amphion does not yet have full details of the application of the sale proceeds, but expects them to total USD2.5 million.

Amphion said it remains "highly cash constrained", and it had hoped to avoid "significant" sales of Polarean shares whilst it considers both short and medium-term financing options and works with debt providers.

"The directors consider it to be unfortunate repayment of the facility required the sale of Amphion's shares in Polarean. Amphion remains committed to Polarean's success and looks forward to supporting the company in the future," Amphion said in its statement Friday.

Amphion shares remain suspended due to the failure to publish audited financial statements for 2018 by June 30. Polarean shares were trading 1.1% higher in London on Friday at 22.75 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
21 May 2019 12:23

Polarean Imaging Confirms USD1 Million Cystic Fibrosis Trial Grant

LONDON (Alliance News) - Polarean Imaging PLC said Tuesday it had its third USD1 million tranche of a study grant confirmed for its late stage trial of xenon medical imaging for children being for

Read more
13 May 2019 10:44

Polarean Imaging Progresses On Clinical Trials, To Add New Trial Site

LONDON (Alliance News) - Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve a

Read more
29 Apr 2019 11:44

Polarean Imaging Hires Charles Osborne As Chief Financial Officer

LONDON (Alliance News) - Medical imaging firm Polarean Imaging PLC said Monday it has hired Charles Osborne as its new chief financial officer with immediate effect.Osborne is currently the

Read more
29 Apr 2019 09:24

Polarean names Charles Osborne as new CFO

(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.

Read more
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
15 Feb 2019 13:46

Polarean Imaging Wins Polarizer System Order From Canadian University

LONDON (Alliance News) - Medical imaging products manufacturer Polarean Imaging PLC said Friday that it has secured a order for its latest polarizer system from the University of British Columbia

Read more
15 Feb 2019 10:27

Polarean Imaging enters contract with University of British Columbia

(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.

Read more
3 Jan 2019 11:45

Amati AIM VCT Builds Over 8% Holding In Polarean Imaging (ALLISS)

LONDON (Alliance News) - Polarean Imaging PLC on Thursday said Amati AIM VCT PLC now holds 8.5% stake in the noble gas polarizer devices manufacturing company.Prior to a transaction on AIM

Read more
11 Dec 2018 13:41

Tuesday broker round-up

(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.

Read more
6 Nov 2018 13:55

Polarean Installs Polariser At University Of Missouri, Gets New Order

LONDON (Alliance News) - Polarean Imaging PLC on Tuesday said it installed and commissioned the latest model of its Xenon polariser to the department of Radiology at University of Missouri Health

Read more
3 Oct 2018 10:19

Polarean Imaging Delivers Xenon Polariser To University Of Missouri

LONDON (Alliance News) - Medical technology company Polarean Imaging PLC on Wednesday said the latest model of its Xenon polariser has been delivered to the radiology department at University of

Read more
23 Aug 2018 15:44

UPDATE: Polarean Imaging Enrols First Patient In 129-Xenon MRI Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more
23 Aug 2018 14:53

Polarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon

(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.

Read more
23 Aug 2018 11:18

Polarean Imaging Enrols First Patient In 129-Xenon MRI Phase III Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.